Nicotine metabolism principally can take place inside the liver. For that reason, when nicotine is administered throughout the GI procedure, it undergoes initial-pass metabolism with the liver, bringing about a bioavailability of only about twenty%. This process inherently decreases the bioavailability of nicotine within the procedure and may lead